GI-Hep Biobank (SickKids), Canada

Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Registration Status: Completed

Objective: The overarching objective of the GI-Hep Biobank is the conservation of material (e.g., DNA, RNA, serum, stool, urine, gastrointestinal/liver tissue, etc.), and data (e.g., clinical data, genetic data) collected from 1) patients with IBD, IBD-associated liver disease, chronic diarrhea/enteropathy, and other related conditions, 2) their biological relatives (affected or unaffected), and 3) controls (healthy or with a health condition other than those of interest to the Biobank), to enable research generally aimed at furthering a precision medicine approach to the management of paediatric GI/hepatic disorders.

Registered Biobank Name	GI-Hep Biobank (SickKids)
Biobank Leader	Hayley McKay
Country	Canada
Email for biobank inquiries	hayley.mckay@sickkids.ca
Principal Investigator	Amanda Ricciuto
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected: